American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2020
  • »
  • May

ALLIANCERX WALGREENS PRIME: Renews sponsorship of web-based continuing education for specialty pharmacists through National Association of Specialty Pharmacy and ProCE, Inc.

American Pharmacy News Reports | May 6, 2020

New courses available in virtual learning center include modules on human immunodeficiency virus, pulmonary arterial hypertension, and influenza Read More »

PTCB: Pharmacy Technician Certification Board Offers Online Testing for First Time in Its History

American Pharmacy News Reports | May 6, 2020

Expands Access to Testing During COVID-19 Read More »

PHARMACISTS UNITED FOR TRUTH AND TRANSPARENCY: Independent Pharmacies Sue Major PBM Over Alleged Illegal Price Discrimination And Reimbursement Violations

American Pharmacy News Reports | May 16, 2020

The newest litigation against a major pharmacy benefit manager (PBM) comes from a likely source: its small business victims. Read More »

INNOVATIVE PHARMACEUTICAL SOLUTIONS: Group shocked by the actions of online platforms towards fighting the COVID-19 pandemic

American Pharmacy News Reports | May 16, 2020

Leading provider of natural wellness solutions, Innovative Pharmaceutical Solutions Group, expresses concern over the activities of online platforms against companies selling PPE items Read More »

COVID-19 vaccine chase evolves into a drama of conflicts and cash

David Beasley | May 20, 2020
Moncef Slaoui with GlaxoSmithKline CEO Emma Walmsley

The U.S. stock market soared Monday on news that biotech company Moderna had achieved positive results in developing a COVID-19 vaccine. Then Tuesday, markets were back down after the publication STAT raised questions about Moderna’s results. Read More »

ALLIANCERX WALGREENS PRIME: One of only two specialty pharmacies to distribute Vyepti™, the first and only intravenous preventive treatment for migraine

American Pharmacy News Reports | May 24, 2020

New medicine one of several limited distribution drugs available through specialty pharmacy Read More »

PANTHERx® Rare Pharmacy Selected by Deciphera Pharmaceuticals to Distribute QINLOCK™ (ripretinib), for Gastrointestinal Stromal Tumor (GIST) Patients

American Pharmacy News Reports | May 24, 2020

PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals as a limited distribution partner for new drug QINLOCK™ (ripretinib). Read More »

U.S. considering international reference pricing for pharmaceutical drugs

American Pharmacy News Reports | May 25, 2020

International reference pricing (IRP) for drugs is under consideration in the U.S. as health care experts are discussing an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting to be held annually. Read More »

Holograms could be key in fight against fake drugs

David Beasley | May 27, 2020

Holograms could be a key tool in fighting fake pharmaceuticals, according to a story in European Pharmaceutical Manufacturer. Read More »

PHIO: Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity

American Pharmacy News Reports | May 31, 2020

The new data was presented at the ASCO 2020 Virtual Scientific Program Read More »

ACELRX PHARMACEUTICALS: Announces Revised Merger Agreement with Tetraphase

American Pharmacy News Reports | May 31, 2020

Under revised terms, AcelRx to acquire Tetraphase for $37.0 million in stock and cash plus CVRs Read More »

Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up